معرفی
Adjunct Professor Marius Trøseid is an academic leader at the University of Oslo's Research Institute for Internal Medicine, dual-affiliated with Oslo University Hospital. He specializes in clinical microbiota science, leading national and EU-funded studies like the Microbiota network and the EU SolidAct trial. His work bridges infectious diseases, immunology, and chronic inflammatory conditions, with a focus on gut microbiome interventions in HIV, heart failure, and post-COVID-19 complications. He pioneered sequencing-based microbiota profiling applied in randomized controlled trials (RCTs) for probiotics, antibiotics, and lifestyle interventions. Recent efforts address SARS-CoV-2 through roles in the WHO Solidarity Trial and EU-RESPONSE network. Key projects include the GutHeart trial (microbiota in heart failure) and CoMicS study (HIV comorbidities).
Research interests emphasize microbiota-cardiovascular/metabolic links, inflammation pathways, and translational clinical trials. Over 100+ publications span gut-brain-heart axes, cytokine profiling, and pandemic preparedness. He coordinates multi-center adaptive trials like Bari-SolidAct (baricitinib efficacy) and the first-in-human microbiota-based screening for anal cancer in HIV+ individuals.
